Contineum Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Assets | |||
| Cash & Equivalents | $75.6M | $21.9M | $15.5M |
| Accounts Receivable | — | — | — |
| Inventory | — | — | — |
| Total Current Assets | $267.9M | $206.4M | $127.7M |
| Property, Plant & Equipment | $830.0K | $989.0K | $678.0K |
| Goodwill | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — |
| Total Assets | $276.6M | $212.8M | $130.4M |
| Liabilities | |||
| Accounts Payable | $1.0M | $1.8M | $635.0K |
| Total Current Liabilities | $9.7M | $10.0M | $5.5M |
| Long-Term Debt | — | — | — |
| Total Liabilities | $15.7M | $14.8M | $5.7M |
| Stockholders' Equity | |||
| Retained Earnings | $-177.4M | $-117.4M | $-75.1M |
| Total Stockholders' Equity | $261.0M | $198.1M | $-67.9M |